Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 36,600 shares at $40.18 ($1.5M) on 2007-07-03, disclosed to the SEC on 2007-07-05.
Scheduled sale ($1.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.24 | 100 | $4K | 0.3% |
| 2 | $39.25 | 900 | $35K | 2.4% |
| 3 | $39.26 | 600 | $24K | 1.6% |
| 4 | $40.00 | 23,175 | $927K | 63.3% |
| 5 | $40.01 | 2,012 | $81K | 5.5% |
| 6 | $40.02 | 1,087 |
| $44K |
| 3.0% |
| 7 | $40.03 | 575 | $23K | 1.6% |
| 8 | $40.04 | 1,684 | $67K | 4.6% |
| 9 | $40.05 | 367 | $15K | 1.0% |
| 10 | $40.07 | 600 | $24K | 1.6% |
| 11 | $40.11 | 600 | $24K | 1.6% |
| 12 | $40.14 | 300 | $12K | 0.8% |
| 13 | $40.18 | 500 | $20K | 1.4% |
| 14 | $40.19 | 2,030 | $82K | 5.6% |
| 15 | $40.20 | 100 | $4K | 0.3% |
| 16 | $40.21 | 500 | $20K | 1.4% |
| 17 | $40.22 | 470 | $19K | 1.3% |
| 18 | $40.23 | 454 | $18K | 1.2% |
| 19 | $40.24 | 446 | $18K | 1.2% |
| 20 | $40.25 | 100 | $4K | 0.3% |
| Total | $40.00 avg | 36,600 | $1.5M | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |